DENVER, April 25 /PRNewswire-FirstCall/ -- Avitech Lifesciences Inc. -- has developed an all natural anti-viral product to add to their already existing line of products. This new all natural anti-viral product has been formulated to help strengthen the body's immune system and aid against many active strains of influenza. Added benefits from the product may include purification of the liver, improved libido and improved endurance and energy levels. The product will be available in capsule form initially. CMI Manufacturing has been commissioned by Avitech Lifesciences to develop the product. CMI Manufacturers Inc. is well known for successfully producing some of the most innovative nutraceutical, pharmaceutical and cosmetic formulations that are available on the world wide market today.
Please visit our websites at http://www.avi-essence.com or http://www.aviessence.com for further information.
About Avitech Lifesciences Inc.
Avitech Lifesciences Inc. is a firm focused on health and life sciences industry. Avitech helps entrepreneurs accelerate their business development by investing early in the company's development and taking an active role in its day to day operations by acting as collaborative partners with the companies we bring on board. Although Avitech Lifesciences Inc.'s primary mandate is health and life sciences sector, the company's mandate will allow it to look at all investments to increase shareholder value.
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward- looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.
Avitech Lifesciences Inc.
CONTACT: Dale Boyd, Investor Relations of Avitech Lifesciences Inc.,+1-303-865-7601